Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide plus tiotropium versus either agent alone in COPD
2005-004434-40Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Seretide Accuhaler + Spiriva, Spiriva alone and Seretide Accuhaler alone (3 arms). Primary endpoint: AUC(0-4hr) specific airway conductance after morning dose at Day 14. Started Nov 2005; status: completed.
02
Drugs
salmeterol + fluticasonetiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-004434-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004434-40.